MAPT and supranuclear palsy, progressive, 1: Although the clinicopathological correlations are very high for both PSP (Pansuwan et al., 2023) and bvFTD, post-mortem diagnoses are required in further work to distinguish between tau versus TDP43 pathology in bvFTD.